Pediatrix Medical Group, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Pediatrix Medical Group, Inc. (MD) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of $165.39 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-02-19
- Pediatrix Medical Group, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $33.68M, a 10.51% increase year-over-year.
- Pediatrix Medical Group, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $71.71M, a 268.85% increase year-over-year.
- Pediatrix Medical Group, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-06-30 was $39.26M.
- Pediatrix Medical Group, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-03-31 was $20.74M, a 413.93% increase year-over-year.
- Pediatrix Medical Group, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was $165.39M.
- Pediatrix Medical Group, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$99.07M.
- Pediatrix Medical Group, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$60.41M, a 191.07% decline from fiscal 2022.
- Pediatrix Medical Group, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was $66.33M, a 49.34% decline from fiscal 2021.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $33.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $105.39M derived: sum of 2 quarters · filed 2026-02-19 | $144.65M derived: sum of 3 quarters · filed 2026-02-19 | $165.39M 10-K · filed 2026-02-19 | |
| 2025-09-30 | $71.71M 10-Q · filed 2025-11-03 | $110.97M derived: sum of 2 quarters · filed 2025-11-03 | $131.71M 10-Q · filed 2025-11-03 | $162.19M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2025-06-30 | $39.26M 10-Q · filed 2025-08-05 | $60.00M 10-Q · filed 2025-08-05 | $90.48M derived: sum of 3 quarters · filed 2026-02-19 | $109.92M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2025-03-31 | $20.74M 10-Q · filed 2025-05-06 | $51.22M derived: sum of 2 quarters · filed 2026-02-19 | $70.66M derived: sum of 3 quarters · filed 2026-02-19 | -$82.37M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-12-31 | $30.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $49.92M derived: sum of 2 quarters · filed 2026-02-19 | -$103.10M derived: sum of 3 quarters · filed 2026-02-19 | -$99.07M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $19.44M 10-Q · filed 2025-11-03 | -$133.58M derived: sum of 2 quarters · filed 2025-11-03 | -$129.55M 10-Q · filed 2025-11-03 | -$253.84M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-06-30 | -$153.03M 10-Q · filed 2025-08-05 | -$148.99M 10-Q · filed 2025-08-05 | -$273.28M derived: sum of 3 quarters · filed 2026-02-19 | -$251.89M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-03-31 | $4.04M 10-Q · filed 2025-05-06 | -$120.25M derived: sum of 2 quarters · filed 2026-02-19 | -$98.86M derived: sum of 3 quarters · filed 2026-02-19 | -$70.58M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2023-12-31 | -$124.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$102.90M derived: sum of 2 quarters · filed 2026-02-19 | -$74.61M derived: sum of 3 quarters · filed 2026-02-19 | -$60.41M 10-K · filed 2026-02-19 | |
| 2023-09-30 | $21.39M 10-Q · filed 2024-11-01 | $49.67M derived: sum of 2 quarters · filed 2024-11-01 | $63.88M 10-Q · filed 2024-11-01 | $93.54M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-06-30 | $28.28M 10-Q · filed 2024-08-06 | $42.49M 10-Q · filed 2024-08-06 | $72.15M derived: sum of 3 quarters · filed 2025-02-20 | $102.88M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-03-31 | $14.21M 10-Q · filed 2024-05-07 | $43.87M derived: sum of 2 quarters · filed 2025-02-20 | $74.59M derived: sum of 3 quarters · filed 2025-02-20 | $101.73M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2022-12-31 | $29.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $60.39M derived: sum of 2 quarters · filed 2025-02-20 | $87.52M derived: sum of 3 quarters · filed 2025-02-20 | $66.33M 10-K · filed 2025-02-20 | |
| 2022-09-30 | $30.73M 10-Q · filed 2023-11-02 | $57.86M derived: sum of 2 quarters · filed 2023-11-02 | $36.67M 10-Q · filed 2023-11-02 | $84.18M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-06-30 | $27.14M 10-Q · filed 2023-08-03 | $5.94M 10-Q · filed 2023-08-03 | $53.45M derived: sum of 3 quarters · filed 2024-02-20 | $84.24M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-03-31 | -$21.19M 10-Q · filed 2023-05-02 | $26.32M derived: sum of 2 quarters · filed 2024-02-20 | $57.11M derived: sum of 3 quarters · filed 2024-02-20 | $92.11M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2021-12-31 | $47.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $78.30M derived: sum of 2 quarters · filed 2024-02-20 | $113.30M derived: sum of 3 quarters · filed 2024-02-20 | $130.94M 10-K · filed 2024-02-20 | |
| 2021-09-30 | $30.79M 10-Q · filed 2022-11-03 | $65.79M derived: sum of 2 quarters · filed 2022-11-03 | $83.43M 10-Q · filed 2022-11-03 | $19.13M derived: sum of 4 quarters · filed 2023-02-17 | |
| 2021-06-30 | $35.01M 10-Q · filed 2022-08-04 | $52.64M 10-Q · filed 2022-08-04 | -$11.66M derived: sum of 3 quarters · filed 2023-02-17 | -$52.70M derived: sum of 4 quarters · filed 2023-02-17 | |
| 2021-03-31 | $17.63M 10-Q · filed 2022-04-28 | -$46.66M derived: sum of 2 quarters · filed 2023-02-17 | -$87.71M derived: sum of 3 quarters · filed 2023-02-17 | -$760.14M derived: sum of 4 quarters · filed 2023-02-17 | |
| 2020-12-31 | -$64.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | -$105.34M derived: sum of 2 quarters · filed 2023-02-17 | -$777.78M derived: sum of 3 quarters · filed 2023-02-17 | -$796.49M 10-K · filed 2023-02-17 | |
| 2020-09-30 | -$41.04M 10-Q · filed 2021-10-28 | -$713.48M derived: sum of 2 quarters · filed 2021-10-28 | -$732.19M 10-Q · filed 2021-10-28 | -$722.86M derived: sum of 4 quarters · filed 2022-02-17 | |
| 2020-06-30 | -$672.44M 10-Q · filed 2021-08-06 | -$691.15M 10-Q · filed 2021-08-06 | -$681.82M derived: sum of 3 quarters · filed 2022-02-17 | -$1.94B derived: sum of 4 quarters · filed 2022-02-17 | |
| 2020-03-31 | -$18.71M 10-Q · filed 2021-05-07 | -$9.38M derived: sum of 2 quarters · filed 2022-02-17 | -$1.27B derived: sum of 3 quarters · filed 2022-02-17 | -$1.27B derived: sum of 4 quarters · filed 2022-02-17 | |
| 2019-12-31 | $9.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$1.25B derived: sum of 2 quarters · filed 2022-02-17 | -$1.25B derived: sum of 3 quarters · filed 2022-02-17 | -$1.50B 10-K · filed 2022-02-17 | |
| 2019-09-30 | -$1.26B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$1.26B derived: sum of 2 quarters · filed 2020-11-06 | -$1.51B 10-Q · filed 2020-11-06 | -$1.51B derived: sum of 4 quarters · filed 2020-11-06 | |
| 2019-06-30 | -$8.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$251.12M 10-Q · filed 2020-07-30 | -$251.12M derived: sum of 3 quarters · filed 2020-07-30 | -$251.12M derived: sum of 4 quarters · filed 2020-07-30 | |
| 2019-03-31 | -$242.87M 10-Q · filed 2020-05-07 | -$242.87M derived: sum of 2 quarters · filed 2020-05-07 | -$242.87M derived: sum of 3 quarters · filed 2020-05-07 | -$242.87M derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | $0.00 10-K · filed 2019-02-14 | $0.00 derived: sum of 2 quarters · filed 2019-02-14 | $0.00 derived: sum of 3 quarters · filed 2019-02-14 | $268.63M 10-K · filed 2021-02-18 | |
| 2018-09-30 | $0.00 10-K · filed 2019-02-14 | $65.58M 10-Q · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2019-02-14 | $208.41M 10-Q · filed 2019-11-01 | $199.53M derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-06-30 | $0.00 10-K · filed 2019-02-14 | $79.41M 10-Q · filed 2018-08-02 | $142.84M 10-Q · filed 2019-08-01 | $199.53M derived: sum of 3 quarters · filed 2020-02-20 | $265.41M derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-03-31 | $63.43M 10-Q · filed 2019-05-02 | $199.53M derived: sum of 2 quarters · filed 2020-02-20 | $265.41M derived: sum of 3 quarters · filed 2020-02-20 | $329.11M derived: sum of 4 quarters · filed 2020-02-20 | |
| 2017-12-31 | $136.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $201.98M derived: sum of 2 quarters · filed 2020-02-20 | $265.68M derived: sum of 3 quarters · filed 2020-02-20 | $320.37M 10-K · filed 2020-02-20 | |
| 2017-09-30 | $65.88M 10-Q · filed 2018-11-01 | $129.58M derived: sum of 2 quarters · filed 2018-11-01 | $184.27M 10-Q · filed 2018-11-01 | $262.35M derived: sum of 4 quarters · filed 2018-11-01 | |
| 2017-06-30 | $63.70M 10-Q · filed 2018-08-02 | $118.39M 10-Q · filed 2018-08-02 | $196.47M derived: sum of 3 quarters · filed 2018-08-02 | $292.89M derived: sum of 4 quarters · filed 2018-08-02 | |
| 2017-03-31 | $54.69M 10-Q · filed 2018-05-04 | $132.77M derived: sum of 2 quarters · filed 2018-05-04 | $229.19M derived: sum of 3 quarters · filed 2018-05-04 | $311.52M derived: sum of 4 quarters · filed 2018-05-04 | |
| 2016-12-31 | $78.08M 10-K · filed 2018-02-14 | $174.50M derived: sum of 2 quarters · filed 2018-02-14 | $256.82M derived: sum of 3 quarters · filed 2018-02-14 | $324.60M 10-K · filed 2019-02-14 | |
| 2016-09-30 | $96.42M 10-K · filed 2018-02-14 | $178.75M derived: sum of 2 quarters · filed 2018-02-14 | $246.52M 10-Q · filed 2017-11-01 | $338.93M derived: sum of 4 quarters · filed 2018-02-14 | |
| 2016-06-30 | $82.33M 10-K · filed 2018-02-14 | $150.10M 10-Q · filed 2017-07-28 | $242.51M derived: sum of 3 quarters · filed 2018-02-14 | $333.15M derived: sum of 4 quarters · filed 2018-02-14 | |
| 2016-03-31 | $67.77M 10-K · filed 2018-02-14 | $160.19M derived: sum of 2 quarters · filed 2018-02-14 | $250.82M derived: sum of 3 quarters · filed 2018-02-14 | $334.87M derived: sum of 4 quarters · filed 2018-02-14 | |
| 2015-12-31 | $92.41M 10-K · filed 2017-02-10 | $183.05M derived: sum of 2 quarters · filed 2017-02-10 | $267.10M derived: sum of 3 quarters · filed 2017-02-10 | $335.69M 10-K · filed 2018-02-14 | |
| 2015-09-30 | $90.64M 10-K · filed 2017-02-10 | $174.69M derived: sum of 2 quarters · filed 2017-02-10 | $243.28M 10-Q · filed 2016-10-27 | $331.56M derived: sum of 4 quarters · filed 2017-02-10 | |
| 2015-06-30 | $84.05M 10-K · filed 2017-02-10 | $152.64M 10-Q · filed 2016-07-28 | $240.92M derived: sum of 3 quarters · filed 2017-02-10 | $327.15M derived: sum of 4 quarters · filed 2017-02-10 | |
| 2015-03-31 | $68.59M 10-K · filed 2017-02-10 | $156.87M derived: sum of 2 quarters · filed 2017-02-10 | $243.11M derived: sum of 3 quarters · filed 2017-02-10 | $322.13M derived: sum of 4 quarters · filed 2017-02-10 | |
| 2014-12-31 | $88.28M 10-K · filed 2016-02-11 | $174.52M derived: sum of 2 quarters · filed 2016-02-11 | $253.54M derived: sum of 3 quarters · filed 2016-02-11 | $317.20M 10-K · filed 2017-02-10 | |
| 2014-09-30 | $86.24M 10-K · filed 2016-02-11 | $165.26M derived: sum of 2 quarters · filed 2016-02-11 | $228.92M 10-Q · filed 2015-10-29 | $307.90M derived: sum of 4 quarters · filed 2016-02-11 | |
| 2014-06-30 | $79.03M 10-K · filed 2016-02-11 | $142.69M 10-Q · filed 2015-07-30 | $221.66M derived: sum of 3 quarters · filed 2016-02-11 | $298.62M derived: sum of 4 quarters · filed 2016-02-11 | |
| 2014-03-31 | $63.66M 10-K · filed 2016-02-11 | $142.63M derived: sum of 2 quarters · filed 2016-02-11 | $219.59M derived: sum of 3 quarters · filed 2016-02-11 | $288.81M derived: sum of 4 quarters · filed 2016-02-11 | |
| 2013-12-31 | $78.97M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $155.93M derived: sum of 2 quarters · filed 2016-02-11 | $225.15M derived: sum of 3 quarters · filed 2016-02-11 | $280.52M 10-K · filed 2016-02-11 | |
| 2013-09-30 | $76.96M 10-Q · filed 2014-10-30 | $146.18M derived: sum of 2 quarters · filed 2014-10-30 | $201.54M 10-Q · filed 2014-10-30 | ||
| 2013-06-30 | $69.22M 10-Q · filed 2014-07-31 | $124.58M 10-Q · filed 2014-07-31 | |||
| 2012-12-31 | $240.91M 10-K · filed 2015-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Encompass Health Corp (EHC) | United States | $12.039B | 16.15 |